Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gruber

Showing results (351-360 of 356) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 356 results.
The New England Journal of Medicine|April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsEdward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
The New England Journal of Medicine|March 19, 2015
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adultsMarc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas, et al.
The New England Journal of Medicine|March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 VaccineEdson D Moreira, Nicholas Kitchin, Xia Xu, et al.
The New England Journal of Medicine|November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of AgeEmmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
The New England Journal of Medicine|February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of AgeFlor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
The New England Journal of Medicine|April 5, 2023
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsBeate Kampmann, Shabir A Madhi, Iona Munjal, et al.
Pageof 36

Showing results (351-360 of 356) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 356 results.
The New England Journal of Medicine|April 5, 2023
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older AdultsEdward E Walsh, Gonzalo Pérez Marc, Agnieszka M Zareba, et al.
The New England Journal of Medicine|March 19, 2015
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adultsMarc J M Bonten, Susanne M Huijts, Marieke Bolkenbaas, et al.
The New England Journal of Medicine|March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 VaccineEdson D Moreira, Nicholas Kitchin, Xia Xu, et al.
The New England Journal of Medicine|November 9, 2021
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of AgeEmmanuel B Walter, Kawsar R Talaat, Charu Sabharwal, et al.
The New England Journal of Medicine|February 15, 2023
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of AgeFlor M Muñoz, Lawrence D Sher, Charu Sabharwal, et al.
The New England Journal of Medicine|April 5, 2023
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsBeate Kampmann, Shabir A Madhi, Iona Munjal, et al.
Pageof 36